Boctor A M, Band P, Grossman A
Endocrinology. 1983 Aug;113(2):453-62. doi: 10.1210/endo-113-2-453.
The cytosol fraction of rat pancreas [100,000 X g (for 1 h) supernatant] demonstrated specific but nonsaturable binding of [3H]estradiol in the concentration range of 2-50 X 10(-9) M. Scatchard analysis of specifically bound [3H]estradiol, determined by the isotope dilution technique (competition with excess unlabeled estradiol), indicated a single class of binding sites (approximately 4.4 pmol/mg protein) with an apparent Kd of 5 X 10(-8) M. Such cytosol fractions, prepared from homogenates that contained protease inhibitors, when prelabeled with [3H]estradiol, demonstrated a single sharp eluate peak of radioactivity after Sephadex G-200 chromatography that corresponded to a molecular weight of 120,000. When protease inhibitors were omitted, [3H]estradiol was associated with material of considerably lower molecular weight. Routinely, the protease inhibitors leupeptin (1 mM), phenylsulfonyl fluoride (0.5 mM), and tosylphenylalanylchloromethyl ketone (0.05 mM) were included in the buffer used for homogenizing both the pancreas and uterus. The protein that binds [3H]estradiol in uterus differed from that in pancreas in a number of ways: 1) in the range of 10-20 X 10(-9) M [3H]estradiol, specific binding of the hormone to uterine sites was saturable, and Scatchard analysis indicated a single class of binding sites, (approximately 0.5 pmol/mg protein) having an apparent Kd of 3 X 10(-10) M; 2) the rate constants of dissociation of the [3H] estradiol-bound complexes in pancreas and uterus were 3.1 X 10(-4) sec-1 (t1/2, 37 min) and 8.7 X 10(-5) sec-1 (t1/2, 134 min), respectively; 3) the molecular weight of the estrogen-binding protein in freshly prepared uterine supernatant fractions appeared to be at least 240,000; this was unaltered regardless of whether protease inhibitors were present during initial homogenization of the tissue; and 4) when uterine supernatants prepared in the absence of protease inhibitors were kept at 8 C for 24 h and then analyzed by Sephadex G-200 chromatography, a second peak of [3H]estradiol-binding activity appeared at the same eluate volume as the low molecular weight binding fractions of pancreas. These data suggest that although the binding proteins in pancreas and uterus are different, there may be some common features at the hormone-binding locus.
大鼠胰腺的胞质溶胶部分[100,000×g(1小时)上清液]在2 - 50×10⁻⁹ M的浓度范围内表现出[³H]雌二醇的特异性但不饱和结合。通过同位素稀释技术(与过量未标记雌二醇竞争)测定的特异性结合的[³H]雌二醇的Scatchard分析表明存在一类单一的结合位点(约4.4 pmol/mg蛋白质),表观解离常数Kd为5×10⁻⁸ M。从含有蛋白酶抑制剂的匀浆中制备的此类胞质溶胶部分,在用[³H]雌二醇预标记后,经Sephadex G - 200层析显示出单一的放射性洗脱峰,对应分子量为120,000。当省略蛋白酶抑制剂时,[³H]雌二醇与分子量低得多的物质相关。通常,在用于胰腺和子宫匀浆的缓冲液中包含蛋白酶抑制剂亮抑酶肽(1 mM)、苯磺酰氟(0.5 mM)和甲苯磺酰苯丙氨酰氯甲基酮(0.05 mM)。子宫中结合[³H]雌二醇的蛋白质在许多方面与胰腺中的不同:1)在10 - 20×10⁻⁹ M [³H]雌二醇范围内,激素与子宫位点的特异性结合是可饱和的,Scatchard分析表明存在一类单一的结合位点(约0.5 pmol/mg蛋白质),表观解离常数Kd为3×10⁻¹⁰ M;2)胰腺和子宫中[³H]雌二醇结合复合物的解离速率常数分别为3.1×10⁻⁴秒⁻¹(半衰期,37分钟)和8.7×10⁻⁵秒⁻¹(半衰期,134分钟);3)新鲜制备的子宫上清液部分中雌激素结合蛋白的分子量似乎至少为240,000;无论在组织初始匀浆过程中是否存在蛋白酶抑制剂,该分子量均未改变;4)当在无蛋白酶抑制剂的情况下制备的子宫上清液在8℃保存24小时,然后通过Sephadex G - 200层析分析时,[³H]雌二醇结合活性的第二个峰出现在与胰腺低分子量结合部分相同的洗脱体积处。这些数据表明,尽管胰腺和子宫中的结合蛋白不同,但在激素结合位点可能存在一些共同特征。